Search - tctmd.com

Displaying 281 - 300 of 549

Sort: Relevancy | Date

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

Presentation ACC 2016

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis

Presenter: Vinod Thourani

April 01, 2016

News Industry News

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

March 16, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

Presentation JIM 2016

SAPIEN 3: Current Experience

Presenter: Martin B. Leon

February 09, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Michael O'Riordan

February 08, 2016

News Daily News

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

L.A. McKeown

February 07, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

Presentation

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

Presenter: Oliver Husser

February 04, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

News Industry News

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

January 14, 2016

News Daily News

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Michael O'Riordan

December 27, 2015

News Daily News

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

Michael O'Riordan

December 27, 2015

News Daily News

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

Michael O'Riordan

December 27, 2015

News Daily News

报告首次概述了商业化 TAVR 的经验

Todd Neale

November 30, 2015

News Daily News

Un Informe Ofrece una Visión de la Experiencia Comercial Inicial de la TAVR

Todd Neale

November 30, 2015

News Daily News

Report Provides Snapshot of Initial Commercial TAVR Experience

Todd Neale

November 30, 2015

Advertisement

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-Risk Patients: A Propensity Score Analysis

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

SAPIEN 3: Current Experience

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

Predictors of Permanent Pacemaker Implantations and New-Onset Conduction Abnormalities With Sapien 3

FDA Grants Go-Ahead for Low-Risk TAVR Study

Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve

Sapien 是经导管肺动脉瓣置换的“可行、持久”方案

Sapien a ‘Viable and Durable’ Option in Transcatheter Pulmonary Valve Replacement

La Sapien es una Opción ‘Viable y Duradera’ en la Sustitución Transcatéter de la Válvula Pulmonar

报告首次概述了商业化 TAVR 的经验

Un Informe Ofrece una Visión de la Experiencia Comercial Inicial de la TAVR

Report Provides Snapshot of Initial Commercial TAVR Experience

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content